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OBJECTIVE: Women with chronic kidney disease (CKD) are
often at risk of experiencing polypharmacy. Polypharmacy is
deﬁned as the excessive use of drugs. This study examined varia-
tions in numbers of medications used by women with CKD in
outpatient settings in the United States. METHODS: This cross-
sectional study used data from the National Ambulatory Medical
Care Survey (NAMCS) from 1996–2003. Women aged 18 years
and older with CKD were included in the study sample based on
clinical diagnoses and the reason for the visit. Polypharmacy was
determined by retrieving number of medications used (5 medi-
cations) during the time of visit (retrieved using the NAMCS
drug codes). All analyses were weighted to make national
estimates. RESULTS: There were approximately 58 million
weighted outpatient visits for women with CKD from 1996 to
2003. The mean age for this population is 62. Nearly 14% of
these visits were by Hispanic women. Nephrologists accounted
for only 15% of CKD patient visits. Just over 4% of women
reported having 8 medications at the time of their visits. Further-
more, 32% of patients were using 5 medications. Multivariate
analysis showed that women seen by nephrologists were about
two times more likely (OR:1.9;95% CI: (1.19–3.30) (p  0.05)
to receive a prescription for 5 medications than those not
seeing a nephrologist. Hispanic women were 54% less likely
(OR:0.46;95% CI: (0.23–0.94) (p  0.05) to receive a prescrip-
tion for 5 medications than non Hispanic patients. Addition-
ally, this study also identiﬁed signiﬁcant regional and time
variations (p  0.05) in polypharmacy trends within this popu-
lation in U. S. outpatient settings. CONCLUSION: The ﬁndings
of this study suggest that polypharmacy is prevalent in this
population within U.S. outpatient settings. Increased awareness
among clinicians is needed regarding the impact of polyphar-
macy on women with CKD in outpatient settings in the U.S.
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OBJECTIVE: Use of home dialysis (HomD) therapies, home
hemodialysis and peritoneal dialysis (PD), comprise approxi-
mately 8% of total dialysis utilization in the United States. The
remainder being hemodialysis (HD) performed in-center. Recent
work suggests 50%ormore dialysis patients could receiveHomD.
The objective of this study is to evaluate whether dialysis facility
characteristics affect HomD use. METHODS: The number of
facility point prevalent (December 31, 2006) dialysis patients on
HomDand facilityHDwas extracted from end-stage renal disease
(ESRD) network annual reports. Data on ownership status (proﬁt/
not-for-proﬁt), chain status (independent or managed/owned by a
chain organization), night shift for dialysis, and the number ofHD
stationswere obtained fromMedicare’s Dialysis Facility Compare
(DFC) database. A regression model was used to estimate the
impact of these factors on utilization of HomD (e.g., percent of
total dialysis patients on HomD). Additional risk adjusters
included a rural/urban indicator, percent of dialysis patients
employed, and percent of dialysis population 18 to 54 years of age.
RESULTS: There were 3480 facilities in the analysis. As the
number of HD patients per HD station increases the percent of
patients on HomD signiﬁcantly decreases at an increasing rate. If
the facility has a late shift, the percent of patients on HomD is 6
percent higher than in facilities without a late shift (p < 0.001). If
a facility is for-proﬁt, a chain organization, or is located in a more
rural area, the percent of patients on HomD signiﬁcantly
decreases. Finally, a facility with the median of 62 or more dialysis
patients has a signiﬁcantly greater use ofHomD.CONCLUSION:
HomD was more common in not-for-proﬁt and independently
managed/owned facilities. The ﬁnancial implications of these
ﬁndings may be signiﬁcant as in-center HD is 37% more costly
than a home option in the Medicare population.
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Medicine Cooperative.
Problem or Issue Addressed: Increased costs and utilization of
GCSF for the treatment of oncology patients within Unimed
Vitoria, without any change in the ASCO indication criteria and
cancer incidence.
Goals: 20% cost reduction of GCSF treatment of oncology
patients through strict compliance of ASCO guidelines.
Outcomes items used in the decision: Cost-effective study on
GCSF indication in different tumors and actual clinical applica-
tion (interest conﬂicting prescription medicine).
Implementation Strategy: Single-observer evaluation of all GCSF
requests and consequent release by the health insurance company
only if the indication met ASCO guideline.
Results: Signiﬁcant GCSF cost and utilization reduction from
December 2005 to December 2007. The utilization reduction in
2006 was 25% followed by another 10% in 2007. The cost
reduction was even greater as a result of direct purchase of the
drug by the health insurance company.
Lessons Learned: Direct purchase of medications by the health
care professional that is responsible for the prescription and drug
distribution may increase drug prescription without scientiﬁc
support.
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Organization: The Health Economics Unit of the University of
the West Indies conducted an investigation into diffusion of
laparoscopic general surgery in Trinidad and Tobago.
Problem or Issue Addressed: The adoption of new health tech-
nologies increasingly requires evidence of effectiveness (and cost-
effectiveness). However, even where such evidence is available, its
inﬂuence in modifying clinician behaviour is variable. Where
current clinical practice resists the adoption of new technologies
with demonstrable cost-effectiveness, then this is likely to lead to
a) sub-optimal health outcomes for patients, and (b) inefﬁcient
and wasteful use of scarce health care resources. Minimally inva-
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